Efficacy of Urinary Follicle-Stimulating Hormone (FSH) Among Poor Responders
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by German Hospital, Istanbul.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
German Hospital, Istanbul
Collaborator:
Bahceci Women Health Care Center
Information provided by:
German Hospital, Istanbul
ClinicalTrials.gov Identifier:
NCT00677573
First received: May 9, 2008
Last updated: NA
Last verified: May 2008
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
We proposed to compare outcomes in women with DOR undergoing ART with rec-FSH + u-HMH with those with u-FSH only in GnRH antagonist protocols.
| Condition | Intervention |
|---|---|
|
Infertility |
Drug: Fostimon |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Comparison of Urinary Purified Follicle-Stimulating Hormone (FSH) and Rec-FSH Among Poor Responders Undergoing Ovarian Stimulation With GnRH Antagonist |
Resource links provided by NLM:
Further study details as provided by German Hospital, Istanbul:
Primary Outcome Measures:
- pregnancy rate per embryo transfer [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- number of oocytes retrieved [ Time Frame: per patient ] [ Designated as safety issue: No ]
| Study Start Date: | May 2008 |
| Estimated Study Completion Date: | November 2008 |
| Estimated Primary Completion Date: | October 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: UrFSH |
Drug: Fostimon
450 IU for 4 days then adjusted
|
Eligibility| Ages Eligible for Study: | 20 Years to 44 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- At least one trial with adequate ovarian stimulation resulted by 4 or less oocytes retrieval.
Exclusion Criteria:
- High responder patients
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00677573
Contacts
| Contact: Ulun Ulug, M.D. | 90-21-2293-2150 ext 14111 | ulunulug@superonline.com |
| Contact: Mustafa Bahceci, M.D | 90-21-2230-0809 | mbahceci@superonline.com |
Locations
| Turkey | |
| Alman Hastanesi | Not yet recruiting |
| İstanbul, Turkey | |
| Contact: Haluk Toygarlı, M.D. 90-21-2293-2150 | |
| Principal Investigator: ulun ulug, M.D. | |
| Sub-Investigator: mustafa bahceci, M.D. | |
| Sub-Investigator: enver kurt, M.D. | |
Sponsors and Collaborators
German Hospital, Istanbul
Bahceci Women Health Care Center
More Information
No publications provided
| Responsible Party: | German Hospital, Istanbul |
| ClinicalTrials.gov Identifier: | NCT00677573 History of Changes |
| Other Study ID Numbers: | ughno1 |
| Study First Received: | May 9, 2008 |
| Last Updated: | May 9, 2008 |
| Health Authority: | Turkey: Ministry of Health |
Keywords provided by German Hospital, Istanbul:
|
ART poor responder GnRH antagonist Gonadotropins |
Additional relevant MeSH terms:
|
Infertility Genital Diseases, Male Genital Diseases, Female Follicle Stimulating Hormone |
Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 22, 2013